Waking Cancer Cells

A protein called Coco rouses dormant breast cancer cells in the lung.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

SLEEPING UGLIES: Breast cancer cells (green label) lie dormant in lung tissue, awaiting a signal to become an active cancer stem cell.COURTESY OF HUA GAO AND FILIPPO GIANCOTTI

The paper H. Gao et al., “The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.” Cell, 150:764-79, 2012. The finding Cancer cells often move around early in tumor development, but can remain dormant for years. Hua Gao and colleagues at the Sloan-Kettering Institute for Cancer Research discovered that dormant breast cancer cells that have migrated to the lung could be roused when they start to express a protein called Coco, which is switched on by an unknown signal from lung tissue and fires up the cell’s transition to an active cancer stem cell. The alarm clock To identify genes involved in metastasis, Gao and colleagues screened fragments of DNA from highly metastatic cancer cells by inserting them into poorly metastatic cancer cells, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development